Medicare Enrolled

Dr. Leonard Marks, M.D.

Optician · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
200 UCLA MEDICAL PLZ STE 140, Los Angeles, CA 90095
3107947152
In practice since 2007 (19 years)
NPI: 1811037450 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marks from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marks? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marks

Dr. Leonard Marks is an optician specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Marks performed 13,870 Medicare services across 2,948 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marks received a total of $774 from 7 pharmaceutical and/or device companies across 27 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marks is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in CA $774 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,870
Medicare services
Top 6% in CA for optician
2,948
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~730 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, ropivacaine hydrochloride, 1 mg 10,504 $0 $5
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
655 $69 $508
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
558 $103 $858
Ertapenem sodium injection, 500 mg
An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg.
462 $11 $246
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
296 $3 $36
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
250 $127 $800
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
247 $206 $1,690
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
232 $69 $626
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
198 $126 $1,085
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
176 $4 $35
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
70 $10 $150
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
32 $21 $92
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
29 $209 $1,125
Prostate radiation therapy needle insertion
A needle or tube is inserted into the prostate to deliver radiation therapy.
26 $673 $5,080
Prostate destruction with imaging guidance
This procedure involves destroying prostate tissue using energy or other methods while using imaging technology to guide the treatment.
24 $627 $50,000
High-intensity ultrasound destruction of prostate cancer
This procedure uses high-intensity ultrasound waves to destroy cancerous tissue in the prostate gland. The treatment is guided by ultrasound imaging accessed through the rectum.
24 $804 $4,021
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
24 $12 $124
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
20 $94 $462
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
16 $64 $407
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
14 $8 $460
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $111 $960
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$774
Total received (2018-2024)
Avg $111/year across 7 years
Bottom 47% in CA for optician
7
Companies
27
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$689 (89.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (11.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$33
2023
$26
2022
$204
2021
$74
2020
$142
2019
$178
2018
$116

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$33
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Hitachi Healthcare Americas Corp.
$321
Rochester Medical Corporation
$204
PFIZER INC.
$85
AngioDynamics, Inc.
$74
ABBVIE INC.
$33
SonaCare Medical, LLC
$31
C. R. Bard, Inc. & Subsidiaries
$26
Top 3 companies account for 78.7% of all-time payments
Associated products mentioned in payments ›
BOTOX · Bard Urinary Drainage Bag · NanoKnife · SonaBlate · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Los Angeles?
Compare opticians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,499
Per 100K population
15.2
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Marks is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Marks experienced with injection, ropivacaine hydrochloride, 1 mg?
Based on Medicare claims data, Dr. Marks performed 10,504 injection, ropivacaine hydrochloride, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marks receive payments from pharmaceutical companies?
Yes. Dr. Marks received a total of $774 from 7 companies across 27 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marks's costs compare to other opticians in Los Angeles?
Dr. Marks's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marks) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →